158 related articles for article (PubMed ID: 22007526)
1. [Chitosan-coated ophthalmic submicro emulsion for pilocarpine nitrate].
Wei J; He HL; Zheng CL; Zhu JB
Yao Xue Xue Bao; 2011 Aug; 46(8):990-6. PubMed ID: 22007526
[TBL] [Abstract][Full Text] [Related]
2. Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles.
Kao HJ; Lin HR; Lo YL; Yu SP
J Pharm Pharmacol; 2006 Feb; 58(2):179-86. PubMed ID: 16451745
[TBL] [Abstract][Full Text] [Related]
3. Micellar solutions of triblock copolymer surfactants with pilocarpine.
Pepić I; Jalsenjak N; Jalsenjak I
Int J Pharm; 2004 Mar; 272(1-2):57-64. PubMed ID: 15019069
[TBL] [Abstract][Full Text] [Related]
4. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 2: Precorneal retention and in vivo pharmacodynamic study.
Rupenthal ID; Green CR; Alany RG
Int J Pharm; 2011 Jun; 411(1-2):78-85. PubMed ID: 21453763
[TBL] [Abstract][Full Text] [Related]
5. Miotic effect and irritation potential of pilocarpine prodrug incorporated into a submicron emulsion vehicle.
Sznitowska M; Zurowska-Pryczkowska K; Janicki S; Järvinen T
Int J Pharm; 1999 Jul; 184(1):115-20. PubMed ID: 10425357
[TBL] [Abstract][Full Text] [Related]
6. A potential carrier based on liquid crystal nanoparticles for ophthalmic delivery of pilocarpine nitrate.
Li J; Wu L; Wu W; Wang B; Wang Z; Xin H; Xu Q
Int J Pharm; 2013 Oct; 455(1-2):75-84. PubMed ID: 23916822
[TBL] [Abstract][Full Text] [Related]
7. Increased partitioning of pilocarpine to the oily phase of submicron emulsion does not result in improved ocular bioavailability.
Sznitowska M; Zurowska-Pryczkowska K; Dabrowska E; Janicki S
Int J Pharm; 2000 Jul; 202(1-2):161-4. PubMed ID: 10915939
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive chitosan-coated cationic microemulsion of dexamethasone for ocular delivery: in vitro and in vivo evaluation.
Kesavan K; Kant S; Singh PN; Pandit JK
Curr Eye Res; 2013 Mar; 38(3):342-52. PubMed ID: 23216079
[TBL] [Abstract][Full Text] [Related]
9. Pilocarpine-loaded chitosan-PAA nanosuspension for ophthalmic delivery.
Lin HR; Yu SP; Kuo CJ; Kao HJ; Lo YL; Lin YJ
J Biomater Sci Polym Ed; 2007; 18(2):205-21. PubMed ID: 17323854
[TBL] [Abstract][Full Text] [Related]
10. Chitosan based nanocarriers for indomethacin ocular delivery.
Badawi AA; El-Laithy HM; El Qidra RK; El Mofty H; El dally M
Arch Pharm Res; 2008 Aug; 31(8):1040-9. PubMed ID: 18787795
[TBL] [Abstract][Full Text] [Related]
11. [Ocular pharmacokinetics of pilocarpine micron emulsion in rabbits].
Xu Y; Chen Z; Song J; Zhang J; Xie L
Zhonghua Yan Ke Za Zhi; 1999 Nov; 35(6):446-8. PubMed ID: 11835858
[TBL] [Abstract][Full Text] [Related]
12. In vivo evaluation of submicron emulsions with pilocarpine: the effect of pH and chemical form of the drug.
Sznitowska M; Janicki S; Zurowska-Pryczkowska K; Mackiewicz J
J Microencapsul; 2001; 18(2):173-81. PubMed ID: 11253934
[TBL] [Abstract][Full Text] [Related]
13. Sulfobutyl ether beta-cyclodextrin (SBE-beta-CD) in eyedrops improves the tolerability of a topically applied pilocarpine prodrug in rabbits.
Järvinen T; Järvinen K; Urtti A; Thompson D; Stella VJ
J Ocul Pharmacol Ther; 1995; 11(2):95-106. PubMed ID: 8564640
[TBL] [Abstract][Full Text] [Related]
14. Cubic and hexagonal liquid crystal gels for ocular delivery with enhanced effect of pilocarpine nitrate on anti-glaucoma treatment.
Xingqi W; Yong Z; Xing L; Yang W; Jie H; Rongfeng H; Shuangying G; Xiaoqin C
Drug Deliv; 2019 Dec; 26(1):952-964. PubMed ID: 31544551
[TBL] [Abstract][Full Text] [Related]
15. A gelatin-g-poly(N-isopropylacrylamide) biodegradable in situ gelling delivery system for the intracameral administration of pilocarpine.
Lai JY; Hsieh AC
Biomaterials; 2012 Mar; 33(7):2372-87. PubMed ID: 22182746
[TBL] [Abstract][Full Text] [Related]
16. Self-assembled hexagonal liquid crystalline gels as novel ocular formulation with enhanced topical delivery of pilocarpine nitrate.
Wang X; Zhang Y; Huang J; Xia M; Liu L; Tian C; Hu R; Gui S; Chu X
Int J Pharm; 2019 May; 562():31-41. PubMed ID: 30878587
[TBL] [Abstract][Full Text] [Related]
17. Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide.
Vandamme TF; Brobeck L
J Control Release; 2005 Jan; 102(1):23-38. PubMed ID: 15653131
[TBL] [Abstract][Full Text] [Related]
18. Thiolated quaternary ammonium-chitosan conjugates for enhanced precorneal retention, transcorneal permeation and intraocular absorption of dexamethasone.
Zambito Y; Di Colo G
Eur J Pharm Biopharm; 2010 Jun; 75(2):194-9. PubMed ID: 20171277
[TBL] [Abstract][Full Text] [Related]
19. Mucoadhesive properties of chitosan-coated ophthalmic lipid emulsion containing indomethacin in tear fluid.
Yamaguchi M; Ueda K; Isowaki A; Ohtori A; Takeuchi H; Ohguro N; Tojo K
Biol Pharm Bull; 2009 Jul; 32(7):1266-71. PubMed ID: 19571396
[TBL] [Abstract][Full Text] [Related]
20. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride.
Miyazaki S; Suzuki S; Kawasaki N; Endo K; Takahashi A; Attwood D
Int J Pharm; 2001 Oct; 229(1-2):29-36. PubMed ID: 11604255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
